Hematopoietic Cancer Due to Defective Philips CPAP Devices

The Connection Between Polyurethane Foam and Hematopoietic Cancer

The formation of blood cellular components is medically known as hematopoiesis. Accordingly, hematopoietic cancer refers to malignant diseases that affect the immune system cells. Hematopoietic cancer damages the blood, lymph, bone marrow, and lymphatic system. It is worthy of note that hematological cancer is another term for hematopoietic cancer.

The polyurethane foam present in Philips CPAP, BiPAP, and ASV sleep apnea devices contains 2 chemicals that are carcinogenic, namely methylene diphenyldiisocyanate and toluene diisocyanate. When the polyurethane foam deteriorates, it begins releasing these harmful substances, and people who use the defective machines and ventilators unavoidably inhale them.

Once methylene diphenyldiisocyanate and toluene diisocyanate enter the body via inhalation, they immediately reach the bloodstream, which will carry the carcinogens to every organ and tissue in the body. However, it is important to know that a large portion of methylene diphenyldiisocyanate and toluene diisocyanate will remain in the bloodstream, whose cells they may eventually damage.

As a consequence, you will develop hematopoietic cancer, which can be leukemia, myeloma, or lymphoma. If using a faulty Philips sleep apnea device has taken a toll on your health, we encourage you to reach out to our expert team, who will help you find out whether you qualify for compensation from the liable company.

The Eligibility Requirements for Filing a Philips CPAP Claim for Hematopoietic Cancer

Everyone who came to struggle with hematopoietic cancer as a result of using a defective Philips sleep apnea device should seek financial compensation for their suffering, as not only will taking action provide you with more money to afford better treatment, but it will also hold the company responsible for negligence. Nonetheless, before filing your claim, you must meet the following eligibility criteria:

• you must have a definitive hematopoietic cancer diagnosis
• you must have used your faulty Philips sleep apnea device for at least 6 months
• the claim must be filed within the statute of limitations

As a crucial aspect when it comes to filing product liability claims, the statute of limitations concerns the period of time during which you can take legal action. It is 3 years from the moment of diagnosis in most states, but it ranges between 1 and 6 years throughout the country. For this reason, it is very important to contact Atraxia Law as soon as you receive your hematopoietic cancer diagnosis, as the process of evaluating your case is quite complex.

File Your Philips CPAP Claim for Hematopoietic Cancer with Our Expert Assistance

Our team of professionals has over 35 years of experience in providing assistance to people whose health was affected by defective products, and we will do all in our power to help you recover the compensation you deserve for your suffering if you developed hematopoietic cancer after using a faulty Philips sleep apnea device. The documents you will have to send us are proof of you owning a defective Philips sleep apnea machine or ventilator and your medical records, which must clearly state your diagnosis.

After a complete and careful assessment of your situation, you will know with certainty whether you are eligible for filing a claim with Philips. If you are, we will promptly put you in touch with a lawyer whose main area of practice is product liability and who will help you obtain the maximum financial compensation you qualify for from the liable company.